Identification and quantification of the molecular species of bilirubin BDG, BMG and UCB by LC‒MS/MS in hyperbilirubinemic human serum
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0313044 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Stephany M Castillo-Castañeda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Liver Research Unit, Medica Sur Clinic & Foundation, Mexico City, Mexico. Hauptthemen laut MEDLINE: Bilirubin, Tandem Mass Spectrometry, Hyperbilirubinemia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and aims Unconjugated bilirubin (UCB) is a byproduct of the heme group that indicates irregularities in the metabolism of several important biological molecules, such as hemoglobin. UCB is processed by hepatic UGT1A1, which catalyzes its conjugation to the metabolites bilirubin diglucuronide (BDG) and bilirubin monoglucuronide (BMG). The serum concentrations of BDG and BMG may indicate liver injury or dysfunction. The aim of this study was to standardize and validate a method for the identification and simultaneous quantification of BMG, BDG and UCB by LC‒MS/MS.
Methods
Liquid‒liquid extraction allows the separation of UCB, BMG and BDG from the serum of healthy subjects or patients with liver injury. Detection and quantification were performed using an LC‒MS/MS method. Compound separation was achieved with a BEH-C18 column at 40°C. The mobile phase was prepared with 5 mM ammonium acetate (pH 6) and acetonitrile, and a flow gradient was applied.
Results
This is the first study to directly quantify BMG and UCB levels in human serum; no postcalculations or correction factors are needed. However, BDG quantification requires calculations and a correction factor. We identified the molecular species with ionic transitions m/z 1+ 585.4 > 299.2 for UCB, 761.3 > 475.3 for BMG, 937.3 > 299.5 for BDG and mesobilirubin 589.4 > 301.3 (IS).
Conclusion
The procedures used in this study allowed the simultaneous identification and quantification of the molecular species of bilirubin, BDG, BMG and UCB. Analysis of the serum levels in patients with hyperbilirubinemia revealed that patients with acute-on-chronic liver failure had elevated levels of these species.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Liver Research Unit, Medica Sur Clinic & Foundation, Mexico City, Mexico.
- Medical, Dental and Health Sciences Master and Doctorate Program, National Autonomous University of Mexico, Mexico City, Mexico.
- Pharmacology Department, National Pediatric Institute, Mexico City, Mexico.
- Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
- Hepatology, General Surgery Department, General Hospital Dr. Manuel Gea González, Mexico City, Mexico.
ORCID-Profile: Liliana Rivera-Espinosa, Jacqueline Cordova-Gallardo, Juan Luis Chávez-Pacheco, Nahum Méndez-Sánchez
Zitieren
APA
Castillo-Castañeda, S. M., Rivera-Espinosa, L., Gómez-Garduño, J., Cordova-Gallardo, J., Chávez-Pacheco, J. L., & Méndez-Sánchez, N. (2024). Identification and quantification of the molecular species of bilirubin BDG, BMG and UCB by LC‒MS/MS in hyperbilirubinemic human serum. PLOS ONE. https://doi.org/10.1371/journal.pone.0313044
Vancouver
Castillo-Castañeda SM, Rivera-Espinosa L, Gómez-Garduño J, Cordova-Gallardo J, Chávez-Pacheco JL, Méndez-Sánchez N. Identification and quantification of the molecular species of bilirubin BDG, BMG and UCB by LC‒MS/MS in hyperbilirubinemic human serum. PLOS ONE. 2024. doi:10.1371/journal.pone.0313044
BibTeX
@article{CastilloCastaeda2024,
author = {Castillo-Castañeda, Stephany M and Rivera-Espinosa, Liliana and Gómez-Garduño, Josefina and Cordova-Gallardo, Jacqueline and Chávez-Pacheco, Juan Luis and Méndez-Sánchez, Nahum},
title = {Identification and quantification of the molecular species of bilirubin BDG, BMG and UCB by LC‒MS/MS in hyperbilirubinemic human serum},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0313044}
}
EUVIMED